Current Liabilities

Deferred Revenue

Roivant Sciences Deferred Revenue increased by 161.1% to $3.05M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 0.4%, from $3.04M to $3.05M. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ4 2018
Last reportedQ1 2026

How to read this metric

An increase is generally positive, signaling strong future demand and cash collection, while a decrease indicates the fulfillment of obligations.

Detailed definition

This represents payments received from customers for goods or services that have not yet been delivered or performed. It...

Peer comparison

Common in subscription and long-term contract businesses; highly indicative of future revenue visibility.

Metric ID: deferred_revenue_current

Historical Data

14 periods
 Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q4 '25
Value$10.15M$13.15M$11.90M$7.80M$12.44M$10.57M$5.80M$4.70M$4.17M$2.66M$3.41M$3.04M$1.17M$3.05M
QoQ Change+29.6%-9.5%-34.5%+59.6%-15.1%-45.1%-19.0%-11.2%-36.2%+28.2%-11.0%-61.5%+161.1%
YoY Change+22.6%-19.6%-51.3%-39.8%-66.5%-74.8%-41.2%-35.3%-72.0%+0.4%
Range$1.17M$13.15M
CAGR-30.9%
Avg YoY Growth-37.7%
Median YoY Growth-40.5%

Frequently Asked Questions

What is Roivant Sciences's deferred revenue?
Roivant Sciences (ROIV) reported deferred revenue of $3.05M in Q4 2025.
How has Roivant Sciences's deferred revenue changed year-over-year?
Roivant Sciences's deferred revenue increased by 0.4% year-over-year, from $3.04M to $3.05M.
What does deferred revenue mean?
Cash received from customers for work that has not yet been completed.